Early tumor shrinkage and depth of response in patients with advanced gastric cancer: a retrospective analysis of a randomized phase III study of first-line S-1 plus oxaliplatin vs. S-1 plus cisplatin

Tomohiro Nishina,Mizutomo Azuma,Kazuhiro Nishikawa,Masahiro Gotoh,Hideaki Bando,Naotoshi Sugimoto,Kenji Amagai,Keisho Chin,Yasumasa Niwa,Akihito Tsuji,Hiroshi Imamura,Masahiro Tsuda,Hirofumi Yasui,Hirofumi Fujii,Kensei Yamaguchi,Hisateru Yasui,Shuichi Hironaka,Ken Shimada,Hiroto Miwa,Terukazu Mitome,Hiroki Kageyama,Ichinosuke Hyodo

Early tumor shrinkage and depth of response in patients with advanced gastric cancer: a retrospective analysis of a randomized phase III study of first-line S-1 plus oxaliplatin vs. S-1 plus cisplatin

2019

Background We investigated early tumor shrinkage (ETS) and depth of response (DpR) using data from the G-SOX study comparing S-1 plus oxaliplatin with S-1 plus cisplatin as the first-line treatment for advanced gastric cancer (AGC).

Keywords:

General surgery
Medicine
Cancer
Cisplatin
Oxaliplatin
Shrinkage
Chemotherapy
Gastroenterology
Abdominal surgery
ECOG Performance Status
Proportional hazards model
Confidence interval
Internal medicine
Hazard ratio
Pathology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations